Dilantin Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

dilantin

viatris limited - phenytoin sodium 100mg; phenytoin sodium 100mg; phenytoin sodium 100mg - capsule - 100 mg - active: phenytoin sodium 100mg excipient: erythrosine gelatin lactose monohydrate magnesium stearate purified talc sucrose sunset yellow fcf titanium dioxide vegetable carbon wheat starch active: phenytoin sodium 100mg excipient: erythrosine gelatin lactose monohydrate magnesium stearate maize starch purified talc sucrose sunset yellow fcf titanium dioxide vegetable carbon active: phenytoin sodium 100mg excipient: confectioner's sugar erythrosine gelatin lactose monohydrate magnesium stearate purified talc sunset yellow fcf titanium dioxide vegetable carbon - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments.

Dilantin Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

dilantin

viatris limited - phenytoin sodium 30.1mg; phenytoin sodium 30mg - capsule - 30 mg - active: phenytoin sodium 30.1mg excipient: gelatin magnesium stearate maize starch purified talc sucrose titanium dioxide vegetable carbon active: phenytoin sodium 30mg excipient: confectioner's sugar gelatin lactose monohydrate magnesium stearate purified talc titanium dioxide vegetable carbon - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments.

Dilantin Infatabs Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

dilantin infatabs

viatris limited - phenytoin 50mg; phenytoin 50mg; phenytoin 50mg - chewable tablet - 50 mg - active: phenytoin 50mg excipient: magnesium stearate purified talc quinoline yellow saccharin sodium spearmint flavour natural 11584 sucrose sunset yellow fcf wheat starch active: phenytoin 50mg excipient: spearmint flavour natural 11584 magnesium stearate maize starch purified talc quinoline yellow saccharin sodium sucrose sunset yellow fcf active: phenytoin 50mg excipient: confectioner's sugar magnesium stearate purified talc quinoline yellow saccharin sodium spearmint flavour natural 11584 sunset yellow fcf - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments.

Dilantin Paediatric Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

dilantin paediatric

viatris limited - phenytoin 6 mg/ml - oral suspension - 30 mg/5ml - active: phenytoin 6 mg/ml excipient: aluminium magnesium silicate carmellose sodium carmoisine citric acid monohydrate ethanol imitation banana flavour 510120e glycerol polysorbate 40 purified water sodium benzoate sucrose sunset yellow fcf terpeneless orange oil vanillin

Eryc Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

eryc

pfizer new zealand limited - erythromycin 270.3mg equivalent to 250 mg of active erythromycin;  ;   - capsule - 250 mg - active: erythromycin 270.3mg equivalent to 250 mg of active erythromycin     excipient: cellacefate diethyl phthalate gelatin lactose monohydrate monobasic potassium phosphate povidone purified water sunset yellow fcf

Inspra Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

inspra

viatris limited - eplerenone 25mg - film coated tablet - 25 mg - active: eplerenone 25mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow ys-1-12524-a purified talc purified water   sodium laurilsulfate - inspra is indicated to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3 to 14 days of an acute myocardial infarction.

Inspra Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

inspra

viatris limited - eplerenone 50mg; eplerenone 50mg - film coated tablet - 50 mg - active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water   sodium laurilsulfate active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water   sodium laurilsulfate - inspra is indicated to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3 to 14 days of an acute myocardial infarction.

Megace Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

megace

pharmacy retailing (nz) ltd t/a healthcare logistics - megestrol acetate 160mg;   - tablet - 160 mg - active: megestrol acetate 160mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose povidone sodium starch glycolate

Micreme H Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

micreme h

viatris limited - hydrocortisone 1%; miconazole nitrate 2% - topical cream - active: hydrocortisone 1% miconazole nitrate 2% excipient: benzyl alcohol cetostearyl alcohol cetyl esters wax octyldodecanol polysorbate 60 purified water sorbitan stearate - micreme h is indicated for the treatment of skin infections caused by yeast, dermatophytes or gram-positive bacteria, in which inflammatory symptoms are predominant. micreme h may also be used for mycotic infections with bacterial superinfection.

Pimafucort Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pimafucort

leo pharma limited - hydrocortisone 1%{relative} (1% overage added); natamycin 1%{relative};  ; neomycin sulfate 0.5%{relative} (10% overage added) - topical cream - active: hydrocortisone 1%{relative} (1% overage added) natamycin 1%{relative}   neomycin sulfate 0.5%{relative} (10% overage added) excipient: cetyl esters wax decyl oleate emulgade f macrogol stearates methyl hydroxybenzoate propyl hydroxybenzoate purified water sodium citrate sorbitan stearate